The age range for EVO ICL™ is determined by the FDA based on clinical trials and studies. Patients who are between the ages of 21 and 45 are typically good candidates for this procedure because their eyes have finished developing, and their prescription has stabilized.1 However, age is not the only factor that is considered when determining whether someone is a good candidate for EVO ICL™. Other factors, such as the health of the patient's eyes and the severity of their refractive error, will also be taken into account.
It is worth noting that doctors may choose to implant lenses outside of the approved age range at their discretion, known as "off-label" use. This decision is generally made on a case-by-case basis and depends upon the patient's individual circumstances and eyes. It is important to discuss the risks and benefits of the EVO ICL™ procedure with your eye doctor, who can help determine if you are a good candidate for the procedure based on your unique situation. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center can help determine if the EVO ICL™ is right for you.
1. FDA Patient Information Booklet. Facts you need to know about Staar Surgical's EVO ICL™ and EVO TICL™
The EVO ICL™ is the most advanced and latest version of the tried-and-true Visian ICL. The Visian ICL has been used for over 15 years and more than 400,000 procedures have been performed with great success. The EVO ICL builds on that success by further improving the design of the lens.
Although the EVO ICL™ has received FDA approval in 202219, the lens has been in use outside of the United States for more than 10 years, and over 2,000,000 ICL’s have been implanted worldwide. The EVO ICL™ builds on the success of the Visian ICL, which has been used for over 15 years and has had a high success rate with over 400,000 procedures performed.
The EVO ICL™ is made from a highly biocompatible material known as collamer, which is a proprietary material that provides excellent optical clarity and is well-tolerated by the eye. The EVO ICL™ has an innovative design that allows for better fitting and alignment within the eye, resulting in improved vision outcomes. Additionally, the EVO ICL™ has a central port that allows for better fluid flow, which reduces the risk of cataract formation and provides better long-term results.
In summary, while the EVO ICL™ is a new lens in the United States, it has been used successfully for over 10 years worldwide and builds upon the success of the Visian ICL. The EVO ICL™'s advanced design and use of highly biocompatible materials make it an excellent option for patients seeking vision correction surgery. To determine if the EVO ICL™ is right for you, it is important to consult with a highly experienced EVO ICL™ ophthalmologist, such as Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center.
1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035
Yes, it is often possible, but not often necessary. If you have a small residual prescription or your vision changes over time, and your corneal thickness and eye health indicate it is safe, you may be able to have a second surgery like LASIK to fine-tune your vision. Fortunately, this is not commonly needed as the success rate with the EVO implantable collamer lens is quite high.
It is important to note that the decision to have LASIK after an EVO ICL™ implantation is dependent on individual circumstances and you should have a complete eye examination. In some cases, LASIK may not be the best option, and other options such as PRK may be considered instead. Additionally, the timing of a LASIK procedure after EVO ICL™ implantation is also an important factor to consider, as the eyes need time to fully heal and stabilize after the initial surgery.
Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center have extensive experience in both EVO ICL™ implantation and LASIK procedures. They can help determine whether LASIK is a viable option for your eyes, and provide guidance on the best timing for the procedure. It is important to follow post-operative instructions closely to ensure proper healing and minimize the risk of complications.
There are always risks associated with any kind of surgery, and like LASIK, the EVO ICL™ is no exception. However, the EVO ICL™ implantable collamer lens procedure is considered a very safe procedure with a low risk of complications.1,4 Some potential risks associated with the EVO ICL™ include glare, halos or double vision, cataracts, increased intraocular pressure, loss of best corrected visual acuity as well as a need for a second surgery, risk of infection or inflammation.16 However, these risks are generally low and can be minimized with proper preoperative evaluation and postoperative care.
Comparatively, LASIK surgery also has a low risk of complications but the specific risks may differ. LASIK carries a slightly higher risk of post-operative dry eyes and the corneal flap created during the surgery may lead to complications, although such issues are rare.2,3,5,6
Ultimately, the choice of which procedure to undergo depends on each individual patient's eyes, lifestyle and health. It is important to have a thorough consultation with an experienced surgeon like Dr. Sandy T. Feldman at Clearview Eye and Laser Medical Center to determine which procedure is right for you and what risks, if any, may be involved for you.
1. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
2. "Is LASIK Safe? What You Need to Know." Refractive Surgery Council, 13 Oct. 2022, https://americanrefractivesurgerycouncil.org/is-lasik-safe/.
3. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13-22.
doi:10.1001/jamaophthalmol.2016.4587. Available: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2587831. Accessed March 1, 2021.
4. FDA Patient Information Booklet. Facts you need to know about Staar Surgical's EVO ICL™ and EVO TICL™
5. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
6. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
This is a difficult question to answer as it depends on each individual patient's eyes, lifestyle and health. The most important question is which procedure is best for YOU. Both the EVO ICL™ and LASIK are very effective methods of vision correction surgery and have a high success rate of achieving spectacle independence.
It is important to note that EVO ICL™ and LASIK are different procedures that correct nearsightedness with or without astigmatism. LASIK corrects vision by reshaping the cornea, while EVO ICL™ involves implanting a lens in the eye. EVO ICL™ is often a better option for patients with very high prescriptions, thin corneas or dry eyes, whereas LASIK may be a better option for patients with moderate to high prescriptions and good corneal thickness.
While LASIK is a more well-known procedure and results of wavefront guided [iDesign LASIK] achieve 20/20 or better vision in more than 95% of patients1, the EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published in the Journal of Refractive Surgery found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK. Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas or other factors.2
Both procedures have a high patient satisfaction rate, 96% for LASIK and 99.4% of the EVO ICL™.3-5
While LASIK is a more well-known procedure, EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK.6 Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas, higher prescriptions or other factors.
Ultimately, the decision between EVO ICL™ and LASIK should be based on a thorough consultation with a qualified ophthalmologist like Dr. Sandy T. Feldman. She has significant experience in most advanced forms of surgical vision correction available. and can evaluate your eyes and discuss the advantages and disadvantages of each procedure in order to help you make an informed decision about the best way to achieve clear, sharp vision.
1. Manche E, Lu L. A prospective randomized, fellow eye study comparing wavefront guided and topography guided LASIK surgery. Presentation ASCRS annual meeting 2023.
2. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
3. Staar Survey.
4. "Is LASIK Safe? What You Need to Know." Refractive Surgery Council, 13 Oct. 2022, https://americanrefractivesurgerycouncil.org/is-lasik-safe/.
5. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13-22. doi:10.1001/jamaophthalmol.2016.4587. Available: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2587831. Accessed March 1, 2021.
6. Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Ophthalmol. 2009 Jul;148(1):164-70.
The EVO ICL™is an Implantable Collamer Lens that works in conjunction with the natural lens to correct vision problems such as nearsightedness (myopia) and astigmatism. Unlike traditional contact lenses that are placed on the surface of the eye, the EVO ICL™ is surgically placed just below the surface of the eye, between the iris and the natural lens.
One of the key benefits of the EVO ICL™ is that it is made up of a biocompatible material. The proprietary material is composed of collagen and other naturally occurring compounds found in the body. This allows the lens to be easily accepted by the eye without causing an immune response or rejection.
Another advantage of the EVO ICL™ is its size. At just a few millimeters, the EVO ICL™ lens, is about the size of a button in diameter. The lens is much smaller than a typical soft contact lens. This small size allows for a minimally invasive surgical procedure, with a fast recovery time for patients.
Additionally, the EVO ICL™ offers several other benefits over traditional vision correction methods such as LASIK. Because no tissue is removed from the front surface of the eye during the procedure, patients may experience less dryness and discomfort following surgery. The lens also offers excellent night vision and built-in UV protection.
The EVO ICL™ has been used in over 2 million procedures worldwide, making it a safe and effective option for many patients seeking vision correction surgery. And like all surgical procedures, side effects1 are possible. If you are interested in learning more about the EVO ICL™ and whether it is right for you, contact Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego for a consultation.The EVO ICL™ offers a number of benefits to consider when deciding which vision correction procedure is right for you including:
Because the lens is implanted within the eye, it usually does not suffer from the same potential for displacement, movement, or discomfort as contact lenses on the surface of the eye. This means that patients can enjoy stable, long-term vision correction without the need for frequent adjustments or replacements.
The EVO ICL offers sharp clear vision3 during the day and also at night4-6.
Another advantage of the EVO ICL™ is its biocompatibility. The collamer material used in the lens is well-tolerated by the body, reducing the risk of inflammation, infection, or other complications following surgery. The EVO ICL™ also preserves the cornea, which can be particularly beneficial for patients with thin corneas or those who may not be good candidates for LASIK.
The lens also includes a built-in UV filter, helping to protect the eyes from damage caused by the sun's rays. Patients who choose the EVO ICL™ can enjoy improved vision, greater comfort, and low risk of complications.
At Clearview Eye and Laser Medical Center in San Diego, California, Dr. Sandy T. Feldman is dedicated to helping patients achieve optimal vision. Contact us today to learn more about the benefits of the EVO ICL™ and schedule a free evaluation to determine whether this may be the right option for you.
1.Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009
2. Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125
3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
4. Schallhorn S, Tanzer D, Sanders DR, Sanders M, Brown M, Kaupp SE. Night driving simulation in a randomized prospective comparison of Visian toric implantable collamer lens and conventional PRK for moderate to high myopic astigmatism. J Refract Surg. 2010 May;26(5):321-6.
5. Takashi Kojima, Yoshihiro Kitazawa, Tomoaki Nakamura, Masahide Takahashi, Kazutaka Kamiya, Kazuo Ichikawa, Akihito Igarashi , Kimiya Shimizu. Prospective Randomized Multicenter Comparison of the Clinical Outcomes of V4c and V5 Implantable Collamer Lenses: A Contralateral Eye Study. J Ophthalmology. 2018 Sep 5;2018:7623829.
6. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.
The EVO ICL™ [implantable collamer lens] may be a good solution for people with nearsightedness and astigmatism wanting a flexible and biocompatible vision correction option that does not remove tissue from the eye. It is also a good solution for many patients with high nearsighted prescriptions or thin corneas who are not candidates for laser vision correction.
Ideal candidates for the EVO ICL™:
Patients seeking vision correction who meet the above criteria can consider EVO ICL™ surgery in San Diego. Additionally, patients where dry eye is a concern, may still be candidates for the procedure, as the EVO ICL™ does not generally exacerbate dry eye syndrome. Even patients who have thin corneas or high nearsighted prescriptions, and those who have previously been told they are not a candidate for LASIK or PRK may also benefit from the EVO ICL™.
It is important for patients to undergo a thorough eye examination and consultation with an experienced eye surgeon to determine if they are a good candidate for EVO ICL™ surgery. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will evaluate your medical history, visual acuity, ocular health, pupil size1, and the thickness of their cornea as part of your consultation to ensure the safety and effectiveness of the procedure for your eyes.
At Clearview Eye and Laser Medical Center in San Diego, Dr. Sandy T. Feldman is a recognized leader in refractive surgery and is the #1 EVO ICL™ surgeon in San Diego. She has performed numerous EVO ICL™ procedures with excellent outcomes. Patients who are considering EVO ICL™ surgery can trust Dr. Feldman and her experienced team to provide personalized care and the latest advanced technology for the best possible results for you and your eyes.
1. Lim DH, Lyu IJ, Choi SH, Chung ES, Chung TY. Risk factors associated with night vision disturbances after phakic intraocular lens implantation.�Am J Ophthalmol. 2014 Jan;157(1):135-141.The EVO ICL™ implantation procedure involves several steps to ensure the safety and effectiveness of the treatment for you. Before the procedure, Dr. Sandy T. Feldman and her team will perform a comprehensive eye examination to determine your eligibility for the EVO ICL™ lens implantation. After your initial examination at Clearview to determine that the EVO ICL™ is right for you, you will schedule your procedure. An additional visit is usually necessary prior to the procedure for additional measurements, and a discussion about the benefits as well as risks of the procedure.
The EVO ICL™ procedure typically takes 20 to 30 minutes in an outpatient center. On the day of the procedure, your eyes will be dilated and then in surgery, numbed with a comfort drop (an anesthetic eye drop). Dr. Sandy T. Feldman will implant the EVO ICL™ in the space between the iris (colored part of the eye) and the natural lens and align the lens according to the specifications recommended for your eyes. The lens will remain in place permanently and will not be visible to others. Usually, you cannot feel the lens.
Following the procedure, you may experience some minor discomfort, such as eye irritation or dryness, which can be managed with eye drops or medication. At Clearview Eye and Laser Medical Center, we will re-evaluate your eyes two to four hours after the procedure. Follow up appointments are scheduled to ensure proper healing and to monitor your vision improvement.
Overall, the EVO ICL™ procedure is a safe and effective vision correction option for patients with moderate to severe nearsightedness and astigmatism.1,2 The procedure is quick and can provide long-lasting results, making it an attractive alternative to traditional laser vision correction.
1. Summary of Safety and Efficacy Data, FDA 2022.
2. FDA Patient Education Booklet.�
Yes; although the EVO ICL™ is intended to provide permanent vision correction, it can be removed or upgraded by your surgeon if ever needed.
While the EVO ICL™ is designed to provide long-term vision correction, there are situations in which removal or upgrading may be necessary. For example, if a patient develops cataracts later in life, the EVO ICL™ will be removed at the same time as the cataract procedure.
The process of removing the EVO ICL™ is typically straightforward and can usually be performed in an outpatient setting. Dr. Sandy T Feldman will first numb the eye with local anesthesia to minimize any discomfort during the procedure. The lens is then carefully extracted using specialized instruments and techniques.
After the EVO ICL™ has been removed, patients may experience some temporary vision changes and mild discomfort as their eyes adjust. However, most patients resume normal activities shortly following the procedure.
It is important to note that while the EVO ICL™ can be removed or upgraded if necessary, the vast majority of patients are highly satisfied with their results and do not experience any complications or issues requiring removal. It is always important to determine the best course of action for your individual situation.
No, you should not feel the EVO ICL™ lens once it has been implanted inside your eye. The EVO ICL™ is designed to be a biocompatible and flexible implant that is placed inside the eye to correct nearsightedness and astigmatism. Because of its unique properties, the EVO ICL™ is not typically felt by the patient once it has been implanted.
During the procedure, the EVO ICL™ is carefully placed in the space between the iris and the natural lens of the eye, where it stays in place without any need for sutures or other fixation techniques. Once the lens has been implanted, patients typically experience improved vision without any discomfort or awareness of the lens inside the eye.
As with any surgery, some patients may experience temporary discomfort or sensitivity following the procedure due to the openings that are made. These symptoms are typically mild and can be managed with over-the-counter pain relievers and lubricating eye drops, and usually resolve within a few days.
If you have or have questions about the EVO ICL™ procedure, what to expect during and after the surgery, be sure to discuss these with Dr. Sandy T. Feldman during your consultation. She and her team can help you determine whether the EVO ICL™ is the right choice for your vision correction needs. We are happy to speak with you so feel welcome to call with any questions you may have.
No, you should not feel the EVO ICL™ lens once it has been implanted inside your eye. The EVO ICL™ is designed to be a biocompatible and flexible implant that is placed inside the eye to correct nearsightedness and astigmatism. Because of its unique properties, the EVO ICL™ is not typically felt by the patient once it has been implanted.
During the procedure, the EVO ICL™ is carefully placed in the space between the iris and the natural lens of the eye, where it stays in place without any need for sutures or other fixation techniques. Once the lens has been implanted, patients typically experience improved vision without any discomfort or awareness of the lens inside the eye.
As with any surgery, some patients may experience temporary discomfort or sensitivity following the procedure due to the openings that are made. These symptoms are typically mild and can be managed with over-the-counter pain relievers and lubricating eye drops, and usually resolve within a few days.
If you have or have questions about the EVO ICL™ procedure, what to expect during and after the surgery, be sure to discuss these with Dr. Sandy T. Feldman during your consultation. She and her team can help you determine whether the EVO ICL™ is the right choice for your vision correction needs. We are happy to speak with you so feel welcome to call with any questions you may have.
Yes. Every medical procedure has some risks associated with it. 1-3 Potential complications of the EVO ICL™ procedure, although rare, include inflammation, an increase in eye pressure, infection or the need for an additional procedure, like an EVO ICL exchange. While these potential risks are mitigated as much as possible, they can typically be addressed. Early detection and treatment may allow for few if any long-term side effects but serious side effects can occur.
1. Summary of Safety and Efficacy Data, FDA 2022.>
2. FDA Patient Education Booklet.
3. Zhang H, Gong R, Zhang X, Deng Y. Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation. �Int Ophthalmol. 2022 Nov;42(11):3625-3641.
4. Lim DH, Lyu IJ, Choi SH, Chung ES, Chung TY. Risk factors associated with night vision disturbances after phakic intraocular lens implantation. Am J Ophthalmol. 2014 Jan;157(1):135-141.
Yes, The EVO ICL™ lens has been approved by the US Food and Drug Administration (FDA) for use in the United States1,2. The FDA approval process involves rigorous testing and evaluation to ensure the safety and efficacy of medical devices. The EVO ICL™ lens underwent clinical trials to evaluate its safety and effectiveness, and the results of these trials were submitted to the FDA and approved for use in the United States in March 2022.
In addition to FDA approval, the EVO ICL™ lens has also received approval from regulatory agencies in other countries, including Europe and Japan. This global approval further demonstrates the safety and effectiveness of the EVO ICL™ lens for vision correction.
At Clearview Eye and Laser Medical Center in San Diego, we are proud to be the #1 EVO ICL™ provider in San Diego. We offer it as a safe and effective vision correction option for our patients. Our experienced team, led by Dr. Sandy T. Feldman, has extensive experience with the EVO ICL™ lens and can help determine if it is the right option for you.
1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035
2. https://investors.staar.com/press-releases/press-release-details/2022/STAAR-Surgical-Announces-U.S.-FDA-Approval-of-EVO-Visian-Implantable-Collamer-Lenses/default.aspx
The EVO ICL™ has been used in Europe and Asia for over a decade and more than 2,000,000 procedures have been successfully performed. The EVO ICL™ was available worldwide for about 10 years prior to FDA approval. It is likely the most tested lens of its kind prior to its FDA approval.
At Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman has extensive experience in performing the EVO ICL™ procedure, and she and her team can help determine if this treatment is right for your individual eyes. As with any medical procedure, it is important to discuss the potential risks and benefits with and to carefully follow post-operative instructions to ensure the best possible outcome.
Yes, the EVO ICL™ surgery can treat nearsighted prescriptions, known as myopia, from a low 3 diopters to a high of 20 diopters with or without astigmatism. The amount of astigmatism that can be treated ranges from 1.0 to 4.0 diopters. Above the level of nearsightedness of 15 diopters, the lens will reduce but not fully correct nearsightedness so glasses, contact lenses or laser vision correction may be required. The prescription that is still left can then be treated with laser vision correction if safe for your eyes and you desire to be free of glasses and/or contact lenses.
To determine if you are a suitable candidate for the EVO ICL™ procedure, Dr Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will assess your prescription, eye health, and other factors to determine the most appropriate treatment option for your vision and unique lifestyle needs.
Dr. Sandy T. Feldman is among the most experienced EVO ICL™ surgeons in the US and is the #1 EVO ICL™ surgeon in San Diego, CA. At Clearview, we offer personalized care and use the latest technology to deliver the best possible outcome for each of our patients.
The EVO ICL™, or implantable collamer lens, is designed to be a permanent vision correction solution and last an individual's lifetime. According to clinical studies, the EVO ICL™ has a high rate of long-term success, with many patients reporting stable vision for up to 20 years or more after the procedure.1 In fact, a study published in the Review of Ophthalmology reported that 98.9% of patients who received the EVO ICL™ had 20/32 or better vision at 10 years post-surgery.2
The EVO ICL™�is made up of a biocompatible material called which is a collamer of collagen that is designed to be long-lasting and resistant to degradation and work well in conjunction with your natural eye. The lens is also designed to be reversible, meaning that it can be removed or replaced if necessary. However, this is a rare occurrence and is usually only done in cases of complications or if a patient's vision needs change significantly over time.
The longevity of the EVO ICL™ depends on several factors, including the patient's age, lifestyle, and overall eye health. Regular eye exams and follow-up visits are recommended to ensure that the lens is functioning properly and to monitor any changes in vision or health of the eye over time.
References:The EVO ICL™ procedure is considered worth it for many people who are looking for a permanent solution to their vision problems. The EVO ICL™ procedure is a great alternative to LASIK surgery. Like LASIK, it can even save you money in the long run. When comparing the cost of glasses, contact lenses, contact lens solutions, cases etc., people often see a monetary savings through vision correction surgery. Although more difficult to quantify, you also will also save time as you usually are not dependent on glasses and/or contact lenses.
There is also another immeasurable benefit to you: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.
Studies have shown that patients who undergo EVO ICL™ surgery report high levels of satisfaction with their results. STAAR Surgical. Over 2,000,000 EVO procedures have been performed around the world and 99.4% of patients would have the procedure again.3
Ultimately, whether the EVO ICL™ procedure is worth it for an individual will depend on their specific vision needs and preferences. A consultation with an experienced ophthalmologist like Dr. Sandy T. Feldman can help determine if EVO ICL™ surgery is the right choice for you. At Clearview Eye and Laser Medical Center in San Diego, we have helped many patients achieve clear, crisp vision with EVO ICL™ surgery.
The truly immeasurable benefit to you is: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.
References:Sandy T. Feldman, MD has been performing the Visian implantable collamer lens (ICL) procedure since FDA approval in the U.S. in 2005 and the EVO ICL™ since FDA approval in 2022. She has helped many patients achieve better vision and is the #1 Visian ICL and EVO ICL™ surgeon in San Diego1 and a leading surgeon in the US for this technology as well. As you may have read already on the Clearview Eye and Laser Medical Center website, she is quite experienced and has lectured nationally and internationally on modern vision surgical correction techniques.
Sandy T. Feldman, MD has been performing the implantable collamer lens procedure since FDA approval in the U.S. in 2005 and has helped many patients achieve better vision. She has been the number one Visian ICL and EVO ICL™ surgeon in San Diego2 and a leading surgeon in the US for this technology as well.
Dr. Feldman is a renowned ophthalmologist who has dedicated her career to helping patients improve their vision. She has been practicing for over 25 years and has performed thousands of successful vision correction surgeries. Dr. Feldman has been a pioneer in the field of implantable collamer lenses, including the EVO ICL™, since its inception. She has been performing this procedure for nearly two decades and has extensive experience in selecting the best vision correction procedure for each individual patient. Dr. Feldman is considered one of the top EVO ICL™ surgeons in the country and has been recognized for her expertise by numerous organizations.
In addition to her surgical expertise, Dr. Feldman is also a respected researcher and author in the field of ophthalmology. She has published numerous articles in peer-reviewed journals and has contributed to several textbooks on vision correction surgery. Dr. Feldman is committed to staying at the forefront of her field and regularly attends conferences and training sessions to stay up-to-date on the latest advancements in ophthalmology.
If you are considering EVO ICL™ surgery, Dr. Feldman and the team at Clearview Eye and Laser Medical Center can provide you with the expert care and guidance you need to make an informed decision about your vision.
References:The EVO Implantable Collamer Lens surgery has a very high success rate, with 98.9% of patients achieving uncorrected vision of 20/32 vision or better, and 80% of patients achieving 20/20 uncorrected vision or better.1,2 Patients are so satisfied, that 99.4% of patients say they would have the procedure again.8
The Visian ICL has had success rates as high as 96% of eyes achieving 20/20 or better and 100% of patients achieved 20/20 or better uncorrected vision, three months after surgery in military warfighters.
Dr Sandy T. Feldman is the leading provider of the EVO ICL™ procedure in San Diego and has seen the excellent results resulting in much happiness for our patients at Clearview. Although it is important to understand the general overall success rate of the EVO ICL™, the most important question is if the EVO ICL™ will be successful for your unique vision. To determine if you are a candidate, please schedule a complimentary evaluation with Dr. Sandy T. Feldman and the Team at Clearview Eye and Laser Medical Center today!
Not everyone is a candidate for the EVO ICL™ implantable collamer lens procedure. If your prescription for glasses changes significantly each year, if you have mild nearsightedness [below 3 diopters), moderate to severe damage to the optic nerve from glaucoma or are pregnant, you may not be a good candidate for the EVO ICL™ surgery at this point in time.
In addition to those mentioned above, patients with certain medical conditions such as certain autoimmune diseases or uncontrolled diabetes, as well as those with a history of eye disease such as uveitis or keratitis, may also not be suitable candidates for EVO ICL™ surgery. Patients diagnosed with cataracts should note that every patient's situation is unique, and a thorough consultation with an experienced ophthalmologist such as Dr. Sandy T. Feldman is necessary to determine if EVO ICL™ surgery is a good option for you. It may not be if you already have some clouding of your natural lens. Other implantable lenses may be a better option for you. During the consultation, Dr. Feldman and her team will evaluate your eyes and overall health to determine if you are a suitable candidate for the procedure. It is important to be honest about any medical conditions you have and any medications you are taking during the consultation, as these factors may impact your eligibility for the procedure.
When you undergo a consultation at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will give you a personalized recommendation on which procedure is best for you based on your eyes, lifestyle and health. If EVO ICL™ surgery is not an option for you, Dr. Feldman and her team will work with you to find an alternative solution to meet your vision correction needs.A comprehensive eye examination should be performed to ensure that you are a good candidate for the EVO ICL™ implantable collamer lens. This will include a measurement of your prescription with and without dilation of your eyes. Corneal topography to map the surface of the cornea, intraocular pressure measurement and testing to ensure there is enough space inside your eye where the lens will be positioned. Additionally, a dilated eye exam should be performed as extremely nearsighted people have a higher chance of retinal tears. The size of the eye will help determine the optimal size of ICL to ensure proper fit inside the eye. This information is critical in ensuring that you are a good candidate for the EVO ICL™ surgery. Dr Sandy T. Feldman and the team at Clearview are familiar with EVO ICLs and the necessary testing needed to ensure optimal results.
Most people can return to their normal activities, i.e. work and driving within a day or two after surgery. However, ask Dr. Sandy T. Feldman and her team about the best time to return to work for your type of work. Please follow the instructions you are given. It may take some time to let your eyes heal properly. Although most people can return to their normal activities within a day or two after EVO ICL™ surgery, it is important to follow post-operative instructions provided by Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center. It is recommended to avoid strenuous activities such as heavy lifting or exercise for a week after surgery to prevent complications. Patients should also avoid rubbing their eyes and wear protective eyewear during the recovery period to minimize the risk of infection.
It is common for patients to experience some mild discomfort, blurry vision, and sensitivity to light for a few days after the surgery. Dr. Feldman may recommend using eye drops to alleviate discomfort and aid in the healing process. Patients should also avoid swimming or soaking in hot tubs for two weeks after surgery to prevent infection.
Follow-up appointments with Dr. Feldman will be scheduled to ensure that the healing process is progressing as expected. The number of follow-up visits will depend on individual patient needs. Overall, by following the post-operative instructions and attending follow-up appointments, patients can ensure a successful and speedy recovery after EVO ICL™ surgery.
Vision is usually improved immediately upon sitting up or shortly following surgery and will likely improve from that point.
You should avoid rubbing your eyes, wearing eye makeup, swimming and heavy lifting for at least two weeks after surgery. You should just take it easy and let your eyes recover. You will also need to use medicated eye drops and non-preserved artificial tears.
After undergoing EVO ICL™ implantable collamer lens procedure, there are several precautions that you should take to ensure the best possible outcome. You should avoid rubbing or touching your eyes for at least two weeks after surgery. Rubbing your eyes can lead to irritation or infection, which can slow down the healing process. You should also avoid wearing eye makeup during the first week after the surgery to avoid infection.
Swimming should be avoided for at least two weeks after surgery as the water in the pool or ocean can contain bacteria or other contaminants that can cause infection or irritation. You should also avoid heavy lifting, bending over, or straining for at least a week after surgery to reduce the risk of increased eye pressure, which can affect your vision. You should just take it easy and let your eyes recover.
In addition, Dr. Feldman may prescribe medicated eye drops and non-preserved artificial tears to reduce inflammation, promote healing and prevent dryness. It is important to follow the instructions provided by Dr. Sandy T. Feldman and her team and to attend all follow-up appointments to ensure the best possible results.
The vast majority of patients who have undergone the EVO ICL™ implantable collamer lens no longer rely on corrective lenses for their everyday activities. During the consultation prior to the EVO ICL™, Dr. Sandy T. Feldman and her associates will discuss with you whether this is likely to occur. If you have a prescription above 15 diopters of nearsightedness or greater than 4 diopters of astigmatism, glasses may be needed for certain activities, like driving at night.
According to a study published in the Journal of Cataract and Refractive Surgery, over 95% of patients who received the EVO ICL™ implant reported that they no longer needed glasses or contact lenses for their daily activities.1
It's important to note that there are some cases where glasses may still be needed after the EVO ICL™ surgery. For example, patients with an extremely high degree of nearsightedness or astigmatism may still need glasses for certain activities, such as driving at night. Additionally, some patients may experience minor residual refractive errors, which can be corrected with glasses or additional surgery if needed. The EVO ICL works in harmony with your natural vision. As such, it does not correct for presbyopia so patients who have vision correction with the EVO ICL may need reading glasses for near vision in their mid 40s and later.
During the consultation process at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will discuss the expected outcomes and potential need for glasses following the EVO ICL™ procedure. It's important to follow all post-operative instructions to ensure the best possible results and minimize the need for corrective lenses.
References:The EVO ICL™ is an Implantable Collamer Lens that works in conjunction with your natural lens to correct vision problems such as nearsightedness (myopia) and astigmatism. Unlike traditional contact lenses that sit on the surface of your eye, the EVO ICL™ is surgically implanted just beneath the surface, between the iris and the natural lens.
One of the key benefits of the EVO ICL™ is that it's made from a biocompatible material. This proprietary material, composed of collagen and other naturally occurring compounds in the body, ensures the lens is readily accepted by the eye without triggering an immune response or rejection.
Another advantage of the EVO ICL™ is its size. At just a few millimeters in diameter—about the size of a button—the lens allows for a minimally invasive surgical procedure and a quick recovery time for patients.
Additionally, the EVO ICL™ offers several benefits over traditional vision correction methods such as LASIK. Since no tissue is removed from the cornea during the procedure, patients often experience less dryness and discomfort following surgery. The lens also provides excellent night vision and built-in UV protection.
The EVO ICL™ has been utilized in over 2 million procedures worldwide, establishing it as a safe and effective option for many individuals seeking vision correction surgery. Like all surgical procedures, potential side effects exist. If you are interested in learning more about the EVO ICL™ and determining if it is right for you, please contact Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego for a consultation.
The EVO ICL™ offers a number of benefits to consider when deciding which vision correction procedure is right for you, including:
Because the lens is implanted within the eye, it usually does not suffer from the same potential for displacement, movement, or discomfort as contact lenses on the surface of the eye. This means that patients can enjoy stable, long-term vision correction without the need for frequent adjustments or replacements.
The EVO ICL offers sharp, clear vision3 during the day and also at night4-6.
Another advantage of the EVO ICL™ is its biocompatibility. The collamer material used in the lens is well-tolerated by the body, reducing the risk of inflammation, infection, or other complications following surgery. The EVO ICL™ also preserves the cornea, which can be particularly beneficial for patients with thin corneas or those who may not be good candidates for LASIK.
The lens also includes a built-in UV filter, helping to protect the eyes from damage caused by the sun's rays. Patients who choose the EVO ICL™ can enjoy improved vision, greater comfort, and a low risk of complications.
At Clearview Eye and Laser Medical Center in San Diego, California, Dr. Sandy T. Feldman is dedicated to helping patients achieve optimal vision. Contact us today to learn more about the benefits of the EVO ICL™ and schedule a free evaluation to determine whether this may be the right option for you.
Schedule your free LASIK exam with Dr. Sandy T. Feldman and see how LASIK can change your life.
At Clearview, San Diego's LASIK Center, we treat your vision and comfort like our own. We’re here to address your questions & concerns!
Copyright © 2024 Clearview Eye and Laser Medical Center in San Diego, California. All rights reserved.
LASIK is a medical procedure with risks involved and isn't right for everyone. Individual results may vary. Talk to your eye doctor and consider both the risks and benefits before having the procedure. Additional information can be found at our website or at fda.gov. the material contained on this site is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider.
